Form 4: GeneDx CFO Feeley Reports Stock Transactions

GeneDx Holdings Corp. CFO Kevin Feeley reported the acquisition of performance-based restricted stock units and subsequent sales to cover tax obligations.

Summary

• Kevin Feeley, Chief Financial Officer of GeneDx Holdings Corp. (WGS), reported changes in his beneficial ownership.
• On March 3, 2026, Feeley acquired 15,262 shares of Class A Common Stock upon the certification of achievement of a performance-based restricted stock unit (PRSU) award, which was originally granted on March 15, 2025.
• The vesting of this 2025 PRSU Award was contingent on the achievement of corporate performance metrics related to revenue and adjusted net income, in addition to Feeley's continued service.
• On March 4, 2026, Feeley sold a total of 6,187 shares of Class A Common Stock in multiple transactions at weighted average prices ranging from $77.6261 to $79.2492.
• These sales were specifically conducted to cover tax withholding obligations associated with the vesting and settlement of the 2025 PRSU Award, executed as a 'sell to cover' transaction.
• Additionally, on March 3, 2026, Feeley acquired 10,865 Restricted Stock Units (RSUs), which represent contingent rights to receive Class A Common Stock.
• Following these reported transactions, Feeley beneficially owns 18,674 shares of Class A Common Stock, 122,897 RSUs (representing contingent rights), and options to purchase 25,906 shares of Class A Common Stock.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive filing. While there are sales, they are explicitly for tax purposes following the successful achievement of performance metrics for an equity award, indicating positive company performance leading to the award's vesting.

Positives

• Achievement of corporate performance metrics (revenue and adjusted net income) led to the vesting of the 2025 Performance-Based Restricted Stock Unit (PRSU) Award.
• The acquisition of 15,262 shares of Class A Common Stock from the performance-based award indicates successful performance.
• The acquisition of 10,865 Restricted Stock Units further aligns the CFO's interests with shareholder value.

Negatives

• Sale of 6,187 shares of Class A Common Stock, reducing direct ownership, although explicitly for tax withholding obligations.

Future Outlook

The 10,865 Restricted Stock Units acquired on March 3, 2026, are scheduled to vest annually in 25% tranches, with the first vesting occurring on April 1, 2027, contingent on continued service.

Industry Context

StockSavvy.ai notes that routine insider transactions, such as those reported in a Form 4 for tax-related sales following equity award vesting, are common across industries. While these transactions provide transparency into executive compensation and ownership, they typically do not reflect a change in management's long-term outlook or confidence in the company's strategic direction, especially when explicitly stated as 'sell to cover' for tax obligations.

Comparison to Industry Standards

• Form 4 filings are standard regulatory disclosures for insider transactions across all publicly traded companies in the U.S.
• The 'sell to cover' mechanism for tax withholding on equity awards is a widely adopted practice in executive compensation plans, aligning with common industry standards for managing tax liabilities upon vesting of restricted stock units.
• No specific comparable companies, projects, or results are mentioned in this filing to allow for a direct comparative assessment.

Stakeholder Impact

• Shareholders: The vesting of performance-based awards suggests the company met certain internal performance targets, which could be viewed positively. The sale of shares for tax purposes is a routine event and generally not indicative of a lack of confidence.
• Employees: The vesting of equity awards for the CFO demonstrates the company's compensation structure and the achievement of performance goals, potentially reinforcing confidence in the company's incentive programs.

Next Steps

• The remaining 75% of the 10,865 Restricted Stock Units will vest annually on the anniversary of the grant date, subject to continued service.

Key Dates

Keywords

GeneDx Holdings Corp., WGS, Kevin Feeley, CFO, Form 4, Insider Trading, Stock Transaction, Restricted Stock Units, Performance-Based Award, Equity Compensation, Tax Withholding, Beneficial Ownership